Durvalumab Consolidation After Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety [0.03%]
对于不可切除的III期非小细胞肺癌患者，放化疗后使用度伐利尤单抗维持治疗的有效性和安全性：系统评价和meta分析
Adeena Musheer,Muhammad S Mannan,Muhammad W Khan et al.
Adeena Musheer et al.
Objectives: Durvalumab consolidation following concurrent chemoradiotherapy (CRT) has become the standard of care for patients with unresectable stage III non-small cell lung cancer (NSCLC). However, survival outcomes rep...
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Adverse Events in Patients Receiving Platinum Analog-Based Chemotherapy [0.03%]
葡萄糖酸类肽-1受体激动剂对铂类基化疗患者的上消化道不良事件的影响
Varun Vemulapalli,Carolina C Cruz,Maria J M N Santos et al.
Varun Vemulapalli et al.
Objectives: Many patients with cancer receive chemotherapy alongside glucagon-like peptide-1 receptor agonists (GLP-1 RA) to manage type 2 diabetes or obesity. However, both GLP-1 RA and platinum-based chemotherapies can ...
Racial Distribution of Tenosynovial Giant Cell Tumor: Analysis of Surveillance, Epidemiology, and End Results Database [0.03%]
肿瘤危险监测、流行病学和终末期结果数据库中滑膜巨细胞瘤的种族分布特征分析研究
Felicia Tejawinata,Malena Jhonson,Pingfu Fu et al.
Felicia Tejawinata et al.
Objectives: Tenosynovial giant cell tumor (TGCT) is a rare mesenchymal tumor driven by overexpression of colony-stimulating factor 1 (CSF1) in a few neoplastic synovial cells. Although known to be an ultrarare tumor, the ...
Navigation and Care Coordination in Breast Cancer: Early Findings From a Phase I Clinical Trial [0.03%]
乳腺癌的导航和护理协调：I期临床试验的初步结果
Afua Ofori-Darko,Misty Walker,Ursula J Burnette et al.
Afua Ofori-Darko et al.
Objective: To examine the impact of patient navigation on care coordination, health care access, appointment adherence, psychosocial outcomes, and equity among patients with breast cancer enrolled in the Navigator-Assiste...
Sex Disparities in Postoperative Outcomes Among Patients With Spine Tumors: A Systematic Review [0.03%]
脊柱肿瘤患者的术后结局性别差异：系统回顾
Tobechukwu Ndika,Anushka Peer,Kristina Schaufele et al.
Tobechukwu Ndika et al.
Objectives: Sex-based differences in postoperative outcomes have been reported in nononcologic spine surgery, but their impact among patients undergoing surgery for spine tumors remains poorly understood. We conducted a s...
Outcomes and Toxicities of Radiation Therapy in HIV-Positive Patients With Head and Neck Cancer: A Systematic Review [0.03%]
HIV阳性头颈部肿瘤患者放射治疗的效果和毒性：系统性综述
Linden A Lechner,Florence Mutua,Vivek Ghosh et al.
Linden A Lechner et al.
People living with HIV (PLWH) have an increased incidence of head and neck cancer (HNC), yet the impact of HIV on radiation therapy (RT) outcomes remains poorly defined. To our knowledge, no prior systematic review has synthesized this evid...
Anaplastic Thyroid Carcinoma in the Modern Era: A Population-Based Provincial Analysis [0.03%]
现代时代的甲状腺未分化癌：基于人口的省级分析
Lindsay Barr,Richard Musoke,Alexa Dang et al.
Lindsay Barr et al.
Objectives: Anaplastic thyroid carcinoma (ATC) is a rare and aggressive malignancy. The purpose of this study was to update the outcomes of ATC in a large provincial database in a modern cohort. ...
Vitamin C as an Adjunctive Therapy in Cancer: A Systematic Review and Meta-Analysis of Outcomes in Solid and Hematologic Malignancies [0.03%]
维生素C作为癌症辅助治疗的系统评价和Meta分析：实体瘤与血液系统恶性肿瘤的预后不同
Moazzam Shahzad,Muhammad Kashif Amin,Hafiz Muhammad Hannan Javed et al.
Moazzam Shahzad et al.
Objectives: Vitamin C has gained interest as an adjunctive treatment in oncology due to its antioxidant effects, potential to enhance cancer therapy, and ability to improve quality of life. This systematic review and meta...
PD-1 Inhibition With Camrelizumab in Cervical Cancer: A Systematic Review and Meta-Analysis [0.03%]
卡瑞利珠单抗用于治疗宫颈癌的PD-1抑制作用：系统性回顾和荟萃分析
Adeena Musheer,Muhammad S Mannan,Muhammad W Khan et al.
Adeena Musheer et al.
Objectives: Cervical cancer is the fourth leading cause of cancer mortality in women worldwide. PD-L1 is expressed in 34.4% to 96% of cervical cancers. Camrelizumab is an anti-PD-1 IgG4 antibody with antitumor activity. T...
Targeting HCC With SBRT: Practical Strategies and Immunologic Synergies [0.03%]
立体定向体外放射治疗结合免疫检查点抑制剂治疗肝细胞癌：实用策略和免疫协同效应
Vedin Barve,Neil Newman
Vedin Barve
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, characterized by high recurrence rates despite curative-intent therapies. While surgical resection, ablation, transarterial therapies, and systemi...